MicroRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture

Virology

Volumn 448, Issue , 2014, Pages 247-254

  Xu, Guangwei ^a,b   Gao, Zhenchao ^a,c   He, Wenhui ^a   Ma, Yanting ^a   Feng, Xiaofeng ^a   Cai, Tao ^a   Lu, Fengmin ^d   Liu, Li ^b   Li, Wenhui ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

De novo infection; Hepatitis B virus; Hepatocyte; MicroRNA database; MicroRNA 122; Pathogenesis; RNA deep sequencing; Sodium taurocholate cotransporting polypeptide (NTCP); Tupaia

Indexed keywords

MICRORNA 122; POLYPEPTIDE; RNA ANTIBODY; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STRAIN HEPG2; CHIMPANZEE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; LIVER CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SCANDENTIA; TARGET CELL; TUPAIA BELANGERI; VIRUS CELL INTERACTION;

EID: 84887009429     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.016     Document Type: Article

References (35)

1. Arataki K., Hayes C.N., Akamatsu S., Akiyama R., Abe H., Tsuge M., Miki D., Ochi H., Hiraga N., Imamura M., Takahashi S., Aikata H., Kawaoka T., Kawakami H., Ohishi W., Chayama K. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med. Virol. 2013, 85:789-798.
2. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
3. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., Zaret K.S., Taylor J.M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:106-113.
4. Chen Y., Shen A., Rider P.J., Yu Y., Wu K., Mu Y., Hao Q., Liu Y., Gong H., Zhu Y., Liu F., Wu J. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 2011, 25:4511-4521. (Official Publication of the Federation of American Societies for Experimental Biology).
5. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
6. Dandri M., Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut 2012, 61(Suppl. 1). (i6-17).
7. Fan Y., Huang Z.Y., Cao C.C., Chen C.S., Chen Y.X., Fan D.D., He J., Hou H.L., Hu L., Hu X.T., Jiang X.T., Lai R., Lang Y.S., Liang B., Liao S.G., Mu D., Ma Y.Y., Niu Y.Y., Sun X.Q., Xia J.Q., Xiao J., Xiong Z.Q., Xu L., Yang L., Zhang Y., Zhao W., Zhao X.D., Zheng Y.T., Zhou J.M., Zhu Y.B., Zhang G.J., Wang J., Yao Y.G. Genome of the Chinese tree shrew. Nat. Commun. 2013, 4:1426.
8. Glebe D., Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 2007, 13:22-38.
9. Glebe D., Aliakbari M., Krass P., Knoop E.V., Valerius K.P., Gerlich W.H. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 2003, 77:9511-9521.
10. Hirschman S.Z. The hepatitis B virus and its DNA polymerase: the prototype three-D virus. Mol. Cell Biochem. 1979, 26:47-67.
11. Hsu S.H., Wang B., Kota J., Yu J., Costinean S., Kutay H., Yu L., Bai S., La Perle K., Chivukula R.R., Mao H., Wei M., Clark K.R., Mendell J.R., Caligiuri M.A., Jacob S.T., Mendell J.T., Ghoshal K. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 2012, 122:2871-2883.
12. Janssen H.L., Reesink H.W., Lawitz E.J., Zeuzem S., Rodriguez-Torres M., Patel K., van der Meer A.J., Patick A.K., Chen A., Zhou Y., Persson R., King B.D., Kauppinen S., Levin A.A., Hodges M.R. Treatment of HCV infection by targeting MicroRNA. N. Engl. J. Med. 2013, 368:1685-1694.
13. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
14. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
15. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
16. Lai C.L., Yuen M.F. Chronic hepatitis B-new goals, new treatment. N. Engl. J. Med. 2008, 359:2488-2491.
17. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., Kauppinen S., Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
18. Li C., Wang Y., Wang S., Wu B., Hao J., Fan H., Ju Y., Ding Y., Chen L., Chu X., Liu W., Ye X., Meng S. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J. Virol. 2013, 87:2193-2205.
19. Liu W.H., Yeh S.H., Chen P.J. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim. Biophys. Acta 1809 2011, 678-685.
20. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Nat. Acad. Sci. USA 2008, 105:10513-10518.
21. Murchison E.P., Hannon G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 2004, 16:223-229.
22. Novellino L., Rossi R.L., Bonino F., Cavallone D., Abrignani S., Pagani M., Brunetto M.R. Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs. PLoS One 2012, 7:e31952.
23. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30:2212-2219.
24. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
25. Qiu L., Fan H., Jin W., Zhao B., Wang Y., Ju Y., Chen L., Chen Y., Duan Z., Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem. Biophys. Res. Commun. 2010, 398:771-777.
26. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64:51-68.
27. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Nat. Acad. Sci. USA 1987, 84:1005-1009.
28. Tsai W.C., Hsu S.D., Hsu C.S., Lai T.C., Chen S.J., Shen R., Huang Y., Chen H.C., Lee C.H., Tsai T.F., Hsu M.T., Wu J.C., Huang H.D., Shiao M.S., Hsiao M., Tsou A.P. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 2012, 122:2884-2897.
29. Waidmann O., Bihrer V., Pleli T., Farnik H., Berger A., Zeuzem S., Kronenberger B., Piiper A. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J. Viral Hepatitis 19 2012, e58-e65.
30. Walter E., Keist R., Niederost B., Pult I., Blum H.E. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24:1-5.
31. Wang S., Qiu L., Yan X., Jin W., Wang Y., Chen L., Wu E., Ye X., Gao G.F., Wang F., Chen Y., Duan Z., Meng S. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 2012, 55:730-741.
32. Wen J., Friedman J.R. miR-122 regulates hepatic lipid metabolism and tumor suppression. J. Clin. Invest. 2012, 122:2773-2776.
33. Wright R. Type B hepatitis: progression to chronic hepatitis. Clin. Gastroentero. l 9 1980, 97-115.
34. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., Wang H., Fu L., Song M., Chen P., Gao W., Ren B., Sun Y., Cai T., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012, 1:e00049.
35. Zhong G., Yan H., Wang H., He W., Jing Z., Qi Y., Fu L., Gao Z., Huang Y., Xu G., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. J. Virol. 2013, 87:7176-7184.